Background: Primary healthcare institutions find identifying individuals with dementia particularly challenging. This study aimed to develop machine learning models for identifying predictive features of older adults with normal cognition to develop dementia.
Methods: We developed four machine learning models: logistic regression, decision tree, random forest, and gradient-boosted trees, predicting dementia of 1,162 older adults with normal cognition at baseline from the Hubei Memory and Aging Cohort Study. All relevant variables collected were included in the models. The Shanghai Aging Study was selected as a replication cohort (n = 1,370) to validate the performance of models including the key features after a wrapper feature selection technique. Both cohorts adopted comparable diagnostic criteria for dementia to most previous cohort studies.
Results: The random forest model exhibited slightly better predictive power using a series of auditory verbal learning test, education, and follow-up time, as measured by overall accuracy (93%) and an area under the curve (AUC) (mean [standard error]: 088 [0.07]). When assessed in the external validation cohort, its performance was deemed acceptable with an AUC of 0.81 (0.15). Conversely, the logistic regression model showed better results in the external validation set, attaining an AUC of 0.88 (0.20).
Conclusion: Our machine learning framework offers a viable strategy for predicting dementia using only memory tests in primary healthcare settings. This model can track cognitive changes and provide valuable insights for early intervention.
{"title":"Predicting Progression to Dementia Using Auditory Verbal Learning Test in Community-Dwelling Older Adults Based On Machine Learning.","authors":"Xin-Yan Xie, Lin-Ya Huang, Dan Liu, Gui-Rong Cheng, Fei-Fei Hu, Juan Zhou, Jing-Jing Zhang, Gang-Bin Han, Jing-Wen Geng, Xiao-Chang Liu, Jun-Yi Wang, De-Yang Zeng, Jing Liu, Qian-Qian Nie, Dan Song, Shi-Yue Li, Cheng Cai, Yu-Yang Cui, Lang Xu, Yang-Ming Ou, Xing-Xing Chen, Yan-Ling Zhou, Yu-Shan Chen, Jin-Quan Li, Zhen Wei, Qiong Wu, Yu-Fei Mei, Shao-Jun Song, Wei Tan, Qian-Hua Zhao, Ding Ding, Yan Zeng","doi":"10.1016/j.jagp.2024.10.016","DOIUrl":"https://doi.org/10.1016/j.jagp.2024.10.016","url":null,"abstract":"<p><strong>Background: </strong>Primary healthcare institutions find identifying individuals with dementia particularly challenging. This study aimed to develop machine learning models for identifying predictive features of older adults with normal cognition to develop dementia.</p><p><strong>Methods: </strong>We developed four machine learning models: logistic regression, decision tree, random forest, and gradient-boosted trees, predicting dementia of 1,162 older adults with normal cognition at baseline from the Hubei Memory and Aging Cohort Study. All relevant variables collected were included in the models. The Shanghai Aging Study was selected as a replication cohort (n = 1,370) to validate the performance of models including the key features after a wrapper feature selection technique. Both cohorts adopted comparable diagnostic criteria for dementia to most previous cohort studies.</p><p><strong>Results: </strong>The random forest model exhibited slightly better predictive power using a series of auditory verbal learning test, education, and follow-up time, as measured by overall accuracy (93%) and an area under the curve (AUC) (mean [standard error]: 088 [0.07]). When assessed in the external validation cohort, its performance was deemed acceptable with an AUC of 0.81 (0.15). Conversely, the logistic regression model showed better results in the external validation set, attaining an AUC of 0.88 (0.20).</p><p><strong>Conclusion: </strong>Our machine learning framework offers a viable strategy for predicting dementia using only memory tests in primary healthcare settings. This model can track cognitive changes and provide valuable insights for early intervention.</p>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142792993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-19DOI: 10.1016/j.jagp.2024.11.003
Vimal M. Aga M.D., F.A.P.A.
Brexpirazole was approved for the treatment of nonpsychotic agitation in Alzheimer's disease (AD) dementia by the United States Food and Drug Administration (FDA) in May 2023 after three phase 3 clinical trials found brexpiprazole 2 to 3 mg/day to be an effective and well-tolerated treatment for agitation in AD dementia, albeit with small effect sizes. It appeared to especially benefit dementia patients with severe agitation/aggression, but it took between 6 and 12 weeks across the three studies for the medication to separate from placebo. However, much remains unknown about its place in the psychopharmacological armamentarium for the treatment of AD dementia-related agitation, including the optimal duration of a brexpiprazole trial, bridging options during the time it takes for brexpiprazole to become effective, and whether it should be continued in the presence of or upon emergence of psychosis during treatment. This Research in Action article uses a case vignette to synthesize the findings of the brexpiprazole trials and apply them to clinical practice, highlight the current uncertainties associated with its use, and compare it with other psychopharmacological options for the treatment of agitation in AD dementia.
{"title":"Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia: Clinical Uncertainties and the Path Forward","authors":"Vimal M. Aga M.D., F.A.P.A.","doi":"10.1016/j.jagp.2024.11.003","DOIUrl":"10.1016/j.jagp.2024.11.003","url":null,"abstract":"<div><div>Brexpirazole was approved for the treatment of nonpsychotic agitation in Alzheimer's disease (AD) dementia by the United States Food and Drug Administration (FDA) in May 2023 after three phase 3 clinical trials found brexpiprazole 2 to 3 mg/day to be an effective and well-tolerated treatment for agitation in AD dementia, albeit with small effect sizes. It appeared to especially benefit dementia patients with severe agitation/aggression, but it took between 6 and 12 weeks across the three studies for the medication to separate from placebo. However, much remains unknown about its place in the psychopharmacological armamentarium for the treatment of AD dementia-related agitation, including the optimal duration of a brexpiprazole trial, bridging options during the time it takes for brexpiprazole to become effective, and whether it should be continued in the presence of or upon emergence of psychosis during treatment. This Research in Action article uses a case vignette to synthesize the findings of the brexpiprazole trials and apply them to clinical practice, highlight the current uncertainties associated with its use, and compare it with other psychopharmacological options for the treatment of agitation in AD dementia.</div></div>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":"33 3","pages":"Pages 322-329"},"PeriodicalIF":4.4,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-14DOI: 10.1016/j.jagp.2024.11.001
Rhea Mehta, Jason R Falvey, Chixiang Chen, Yu Dong, Michelle D Shardell, Takashi Yamashita, Denise L Orwig
Objective: Antidepressants are the first-line treatment for depression among older adults. While antidepressants are associated with increased risk of falls and fractures in older adults, their effect on outcomes after fall-related injuries such as hip fracture, and whether these effects differ by sex, is unknown. Thus, the purpose of this study was to examine the association between prefracture antidepressant use and hospital length of stay (LOS) among hip fracture survivors, and related sex differences.
Methods: Participants included 17,936 community-dwelling Medicare fee-for-service beneficiaries with depression and hospitalization claim for hip fracture surgery between 2010 and 2017. Ordinal logistic regression estimated the association between prefracture antidepressant use and hospital LOS in days, categorized into three groups (1-4, 5-8, and 8+ days) during the 30-day postfracture period, adjusting for demographic, medical, facility, and geographic factors. A sex-by-antidepressant use interaction term was included to examine effect heterogeneity by sex.
Results: Prefracture antidepressant users (47%, n = 8,350) were more likely to be younger, White females. The adjusted ordinal logistic regression showed beneficiaries who used antidepressants had 8% higher odds of being in a shorter hospital LOS category compared to non-users (OR = 1.08; 95% CI = 1.02, 1.14; p=0.01). The sex-by-antidepressant use interaction was not statistically significant (p=0.92).
Conclusions: Among older adults with depression who subsequently experienced a hip fracture, antidepressant use of >30 days in the 6 months prior to fracture was associated with a shorter hospital LOS. These findings indicate that use of antidepressants does not prolong early recovery from hip fracture and may be protective.
{"title":"Association Between Prehip Fracture Antidepressant Use and Posthip Fracture Length of Hospital Stay in Medicare Beneficiaries and Assessing Sex Differences.","authors":"Rhea Mehta, Jason R Falvey, Chixiang Chen, Yu Dong, Michelle D Shardell, Takashi Yamashita, Denise L Orwig","doi":"10.1016/j.jagp.2024.11.001","DOIUrl":"10.1016/j.jagp.2024.11.001","url":null,"abstract":"<p><strong>Objective: </strong>Antidepressants are the first-line treatment for depression among older adults. While antidepressants are associated with increased risk of falls and fractures in older adults, their effect on outcomes after fall-related injuries such as hip fracture, and whether these effects differ by sex, is unknown. Thus, the purpose of this study was to examine the association between prefracture antidepressant use and hospital length of stay (LOS) among hip fracture survivors, and related sex differences.</p><p><strong>Methods: </strong>Participants included 17,936 community-dwelling Medicare fee-for-service beneficiaries with depression and hospitalization claim for hip fracture surgery between 2010 and 2017. Ordinal logistic regression estimated the association between prefracture antidepressant use and hospital LOS in days, categorized into three groups (1-4, 5-8, and 8+ days) during the 30-day postfracture period, adjusting for demographic, medical, facility, and geographic factors. A sex-by-antidepressant use interaction term was included to examine effect heterogeneity by sex.</p><p><strong>Results: </strong>Prefracture antidepressant users (47%, n = 8,350) were more likely to be younger, White females. The adjusted ordinal logistic regression showed beneficiaries who used antidepressants had 8% higher odds of being in a shorter hospital LOS category compared to non-users (OR = 1.08; 95% CI = 1.02, 1.14; p=0.01). The sex-by-antidepressant use interaction was not statistically significant (p=0.92).</p><p><strong>Conclusions: </strong>Among older adults with depression who subsequently experienced a hip fracture, antidepressant use of >30 days in the 6 months prior to fracture was associated with a shorter hospital LOS. These findings indicate that use of antidepressants does not prolong early recovery from hip fracture and may be protective.</p>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-08DOI: 10.1016/j.jagp.2024.10.012
Kexin Wang, Ying Cui, Tong Wu
Objective: Tinnitus has been linked to mental health concerns, including suicidal ideation. This study, using data from the National Health and Nutrition Examination Survey (NHANES), investigates the association between tinnitus and suicidal ideation in postmenopausal women, aiming to identify tinnitus as a potential risk factor for suicidal thoughts in this population.
Method: A total of 1,792 postmenopausal women were included after excluding males, premenopausal women, and participants with missing data on tinnitus, suicidal ideation, or key covariates. Multivariable logistic regression models were used to examine the relationship between tinnitus and suicidal ideation, with adjustments for relevant confounders. Data were drawn from the NHANES database, specifically from the 2011 to 2012, 2015 to 2016, and 2017 to 2018 survey cycles.
Results: Of the 1,792 postmenopausal women, 4.41% reported suicidal ideation. Tinnitus prevalence was significantly higher in women with suicidal ideation (P = 0.007). Weighted multivariable logistic regression revealed that women with tinnitus had 2.43 times higher odds of reporting suicidal ideation compared to those without tinnitus (OR: 2.43, 95% CI: 1.07-5.52, P = 0.035).
Conclusion: Tinnitus appears to be a significant factor associated with suicidal ideation in postmenopausal women. These findings underscore the importance of considering tinnitus in mental health assessments, especially among individuals at risk for suicidal thoughts.
{"title":"Association Between Tinnitus and Suicidal Ideation in Postmenopausal Women: An Observational Study.","authors":"Kexin Wang, Ying Cui, Tong Wu","doi":"10.1016/j.jagp.2024.10.012","DOIUrl":"https://doi.org/10.1016/j.jagp.2024.10.012","url":null,"abstract":"<p><strong>Objective: </strong>Tinnitus has been linked to mental health concerns, including suicidal ideation. This study, using data from the National Health and Nutrition Examination Survey (NHANES), investigates the association between tinnitus and suicidal ideation in postmenopausal women, aiming to identify tinnitus as a potential risk factor for suicidal thoughts in this population.</p><p><strong>Method: </strong>A total of 1,792 postmenopausal women were included after excluding males, premenopausal women, and participants with missing data on tinnitus, suicidal ideation, or key covariates. Multivariable logistic regression models were used to examine the relationship between tinnitus and suicidal ideation, with adjustments for relevant confounders. Data were drawn from the NHANES database, specifically from the 2011 to 2012, 2015 to 2016, and 2017 to 2018 survey cycles.</p><p><strong>Results: </strong>Of the 1,792 postmenopausal women, 4.41% reported suicidal ideation. Tinnitus prevalence was significantly higher in women with suicidal ideation (P = 0.007). Weighted multivariable logistic regression revealed that women with tinnitus had 2.43 times higher odds of reporting suicidal ideation compared to those without tinnitus (OR: 2.43, 95% CI: 1.07-5.52, P = 0.035).</p><p><strong>Conclusion: </strong>Tinnitus appears to be a significant factor associated with suicidal ideation in postmenopausal women. These findings underscore the importance of considering tinnitus in mental health assessments, especially among individuals at risk for suicidal thoughts.</p>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-29DOI: 10.1016/S1064-7481(24)00491-3
{"title":"Information for Subscribers","authors":"","doi":"10.1016/S1064-7481(24)00491-3","DOIUrl":"10.1016/S1064-7481(24)00491-3","url":null,"abstract":"","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":"32 12","pages":"Page A1"},"PeriodicalIF":4.4,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142537387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.1016/j.jagp.2024.10.015
Kai Yu, Qingqing Yang, Junjian Wang, Baoqi Zeng
Objectives: To investigate the associations between accelerometer-measured physical activity and sedentary behavior with depression and anxiety.
Methods: We used accelerometer data from the UK biobank. Time spent in moderate-to-vigorous physical activity (MVPA) was classified into four categories: very-low (0-74.9 min/week), low (75-149.9 min/week), moderate (150-299.9 min/week), and high (≥300 min/week). Associations were examined using Cox proportional hazard regression models. Restricted cubic splines were used to evaluate dose-response associations.
Results: A total of 71556 adults (mean [SD] age, 62.11 [7.83] years; 54.5% were female) were included. When stratified by MVPA, 10562 participants were in the very-low group (14.8%), 11578 were in the low group (16.2%), 20700 were in the moderate group (28.9%), and 28716 were in the high group (40.1%). Both MVPA and total physical activity showed nonlinear associations with the risk of depression and anxiety. Compared with very-low level MVPA, moderate MVPA might reduce the risk of depression (HR, 0.71; 95% CI, 0.63-0.79) and anxiety (HR, 0.80; 95% CI, 0.71-0.90). High MVPA was associated with a 30% lower risk of depression (HR, 0.70; 95% CI, 0.62-0.78) and anxiety (HR, 0.70; 95% CI, 0.62-0.79). For sedentary behavior, quartile 4 (≥10.60 h/d) was associated with a 19% higher risk of depression (HR, 1.19; 95% CI, 1.05-1.35) compared to quartile 1 (<8.21 h/d).
Conclusion: The WHO guideline of 150-300 min/week of MVPA may reduce the risk of depression by 29% and anxiety by 20% compared to less than 75 min/week. Prolonged sedentary behavior was associated with a higher risk of depression.
{"title":"Accelerometer-Derived Physical Activity, Sedentary Behavior, and the Risk of Depression and Anxiety in Middle-aged and Older Adults: A Prospective Cohort Study of 71,556 UK Biobank Participants.","authors":"Kai Yu, Qingqing Yang, Junjian Wang, Baoqi Zeng","doi":"10.1016/j.jagp.2024.10.015","DOIUrl":"https://doi.org/10.1016/j.jagp.2024.10.015","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the associations between accelerometer-measured physical activity and sedentary behavior with depression and anxiety.</p><p><strong>Methods: </strong>We used accelerometer data from the UK biobank. Time spent in moderate-to-vigorous physical activity (MVPA) was classified into four categories: very-low (0-74.9 min/week), low (75-149.9 min/week), moderate (150-299.9 min/week), and high (≥300 min/week). Associations were examined using Cox proportional hazard regression models. Restricted cubic splines were used to evaluate dose-response associations.</p><p><strong>Results: </strong>A total of 71556 adults (mean [SD] age, 62.11 [7.83] years; 54.5% were female) were included. When stratified by MVPA, 10562 participants were in the very-low group (14.8%), 11578 were in the low group (16.2%), 20700 were in the moderate group (28.9%), and 28716 were in the high group (40.1%). Both MVPA and total physical activity showed nonlinear associations with the risk of depression and anxiety. Compared with very-low level MVPA, moderate MVPA might reduce the risk of depression (HR, 0.71; 95% CI, 0.63-0.79) and anxiety (HR, 0.80; 95% CI, 0.71-0.90). High MVPA was associated with a 30% lower risk of depression (HR, 0.70; 95% CI, 0.62-0.78) and anxiety (HR, 0.70; 95% CI, 0.62-0.79). For sedentary behavior, quartile 4 (≥10.60 h/d) was associated with a 19% higher risk of depression (HR, 1.19; 95% CI, 1.05-1.35) compared to quartile 1 (<8.21 h/d).</p><p><strong>Conclusion: </strong>The WHO guideline of 150-300 min/week of MVPA may reduce the risk of depression by 29% and anxiety by 20% compared to less than 75 min/week. Prolonged sedentary behavior was associated with a higher risk of depression.</p>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.1016/j.jagp.2024.10.014
David Andrés González, John-Christopher A Finley, Samantha Evy Schoeneman Patel, Jason R Soble
Objectives: To improve assessment of neuropsychiatric symptoms (NPS) by expanding the measurement properties of the Neuropsychiatric Inventory Questionnaire (NPI-Q).
Setting: Several Alzheimer's Disease Research Centers (ADRCs).
Participants: Individuals (n = 45,274) who presented to an ADRC with a collateral and completed the NPI-Q.
Measurements: The NPI-Q total severity score, four NPI-Q subscales, dementia stage, expert NPS rating, consensus rating of dementia syndrome, global cognitive screening, collateral rating of daily functioning, and self-rating of depression.
Results: There was strong evidence of criterion validity with both dementia stage and expert NPS rating for the NPI-Q total severity index, which informed cutoffs and interpretive ranges. Furthermore, subscales had adequate classification of dementia syndromes and appropriate convergent relationships with cognition, daily functioning, and mood. There was good-to-excellent evidence of reliability for the NPI-Q total severity index over several years, and subscales had adequate-to-good reliability.
Conclusions: This is the first study to provide empirically established cutoffs, interpretive ranges, and evidence of reliability over a period longer than a month on the NPI-Q and its subscales. This will improve assessment of NPS in clinical and research contexts.
Article summary: Neuropsychiatric symptoms of neurodegeneration are increasingly understood as early disease markers with tremendous functional impact later in disease, but are often missed or misdiagnosed. The most common measure of these symptoms, the Neuropsychiatric Inventory Questionnaire (NPI-Q), does not have clinically actionable guidance, which this article provided. We established cutscores for several conditions and test-retest reliability over longer periods for the total score and subscales using a multicenter database.
{"title":"Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire.","authors":"David Andrés González, John-Christopher A Finley, Samantha Evy Schoeneman Patel, Jason R Soble","doi":"10.1016/j.jagp.2024.10.014","DOIUrl":"10.1016/j.jagp.2024.10.014","url":null,"abstract":"<p><strong>Objectives: </strong>To improve assessment of neuropsychiatric symptoms (NPS) by expanding the measurement properties of the Neuropsychiatric Inventory Questionnaire (NPI-Q).</p><p><strong>Design: </strong>Multicenter, longitudinal observational study.</p><p><strong>Setting: </strong>Several Alzheimer's Disease Research Centers (ADRCs).</p><p><strong>Participants: </strong>Individuals (n = 45,274) who presented to an ADRC with a collateral and completed the NPI-Q.</p><p><strong>Measurements: </strong>The NPI-Q total severity score, four NPI-Q subscales, dementia stage, expert NPS rating, consensus rating of dementia syndrome, global cognitive screening, collateral rating of daily functioning, and self-rating of depression.</p><p><strong>Results: </strong>There was strong evidence of criterion validity with both dementia stage and expert NPS rating for the NPI-Q total severity index, which informed cutoffs and interpretive ranges. Furthermore, subscales had adequate classification of dementia syndromes and appropriate convergent relationships with cognition, daily functioning, and mood. There was good-to-excellent evidence of reliability for the NPI-Q total severity index over several years, and subscales had adequate-to-good reliability.</p><p><strong>Conclusions: </strong>This is the first study to provide empirically established cutoffs, interpretive ranges, and evidence of reliability over a period longer than a month on the NPI-Q and its subscales. This will improve assessment of NPS in clinical and research contexts.</p><p><strong>Article summary: </strong>Neuropsychiatric symptoms of neurodegeneration are increasingly understood as early disease markers with tremendous functional impact later in disease, but are often missed or misdiagnosed. The most common measure of these symptoms, the Neuropsychiatric Inventory Questionnaire (NPI-Q), does not have clinically actionable guidance, which this article provided. We established cutscores for several conditions and test-retest reliability over longer periods for the total score and subscales using a multicenter database.</p>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-28DOI: 10.1016/j.jagp.2024.10.013
Elliott R Weinstein
{"title":"Answering the Call: Tackling the Epidemic of Poor Mental Health Among Older Adults.","authors":"Elliott R Weinstein","doi":"10.1016/j.jagp.2024.10.013","DOIUrl":"https://doi.org/10.1016/j.jagp.2024.10.013","url":null,"abstract":"","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-23DOI: 10.1016/j.jagp.2024.10.011
Huong Nguyen, Hung Trong Nguyen, Ngoc Bich Nguyen, Duyen Tran, Danielle J Harvey, Binh Thanh Nguyen, Binh Thi Thanh Nguyen, Anh Ngoc Nguyen, Chinh Thi Hong Nguyen, Thu Thi Hoai Nguyen, Thuy Le Nguyen, Anh Thi Phuong Nguyen, Ngoc Hung Nguyen, Anh Lan Nguyen, Yen Hai Luong, Bien Huu Nguyen, Phong Quy Nguyen, Laura N Gitlin, Trung Anh Nguyen, Thang Pham, Ladson Hinton
Objectives: Vietnam faces an unprecedented increase in people living with dementia but lacks evidence-based family dementia caregiver interventions. We tested the efficacy of a culturally adapted family caregiver intervention (REACH VN) in Northern Vietnam.
Methods: In this randomized controlled trial, clusters (communes) were assigned to1 REACH VN (a multicomponent intervention consisting of 4-6 one-hour sessions delivered over 1-3 months) or2 enhanced control (one session of dementia education). Primary outcomes were caregiver perceived psychological distress (PHQ-4) and burden (ZBI-12). Secondary outcomes were caregiver perceived stress (PSS-10) and somatic symptoms (PHQ-15). Mixed effects analysis was performed with 3-month and 6-month assessments as the outcomes and baseline assessment as a covariate.
Results: Overall, 350 caregivers from 40 clusters (21 intervention, 19 enhanced control) enrolled and 330 (94.3%) completed 3-month assessments. At 3 months, the REACH VN intervention group had lower PHQ-4 (p <0.001) but not ZBI-12 (p = 0.05) scores compared to control. At 6 months, the intervention group had lower ZBI-12 (p = 0.002) but not PHQ-4 (p = 0.5) scores. PSS-10 and PHQ-15 scores were also improved at 3 months (p = 0.007, p <0.001 respectively) for the REACH VN intervention group compared with control but not at 6 months.
Conclusions: REACH VN improved outcomes in family caregivers in Vietnam at 3 months although improvement was not sustained for most outcomes at 6 months.
{"title":"Testing the Efficacy of a Culturally Adapted Family Dementia Caregiver Intervention (REACH VN): Results From a Cluster Randomized Controlled Trial in Northern Vietnam.","authors":"Huong Nguyen, Hung Trong Nguyen, Ngoc Bich Nguyen, Duyen Tran, Danielle J Harvey, Binh Thanh Nguyen, Binh Thi Thanh Nguyen, Anh Ngoc Nguyen, Chinh Thi Hong Nguyen, Thu Thi Hoai Nguyen, Thuy Le Nguyen, Anh Thi Phuong Nguyen, Ngoc Hung Nguyen, Anh Lan Nguyen, Yen Hai Luong, Bien Huu Nguyen, Phong Quy Nguyen, Laura N Gitlin, Trung Anh Nguyen, Thang Pham, Ladson Hinton","doi":"10.1016/j.jagp.2024.10.011","DOIUrl":"10.1016/j.jagp.2024.10.011","url":null,"abstract":"<p><strong>Objectives: </strong>Vietnam faces an unprecedented increase in people living with dementia but lacks evidence-based family dementia caregiver interventions. We tested the efficacy of a culturally adapted family caregiver intervention (REACH VN) in Northern Vietnam.</p><p><strong>Methods: </strong>In this randomized controlled trial, clusters (communes) were assigned to<sup>1</sup> REACH VN (a multicomponent intervention consisting of 4-6 one-hour sessions delivered over 1-3 months) or<sup>2</sup> enhanced control (one session of dementia education). Primary outcomes were caregiver perceived psychological distress (PHQ-4) and burden (ZBI-12). Secondary outcomes were caregiver perceived stress (PSS-10) and somatic symptoms (PHQ-15). Mixed effects analysis was performed with 3-month and 6-month assessments as the outcomes and baseline assessment as a covariate.</p><p><strong>Results: </strong>Overall, 350 caregivers from 40 clusters (21 intervention, 19 enhanced control) enrolled and 330 (94.3%) completed 3-month assessments. At 3 months, the REACH VN intervention group had lower PHQ-4 (p <0.001) but not ZBI-12 (p = 0.05) scores compared to control. At 6 months, the intervention group had lower ZBI-12 (p = 0.002) but not PHQ-4 (p = 0.5) scores. PSS-10 and PHQ-15 scores were also improved at 3 months (p = 0.007, p <0.001 respectively) for the REACH VN intervention group compared with control but not at 6 months.</p><p><strong>Conclusions: </strong>REACH VN improved outcomes in family caregivers in Vietnam at 3 months although improvement was not sustained for most outcomes at 6 months.</p>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":" ","pages":""},"PeriodicalIF":4.4,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22DOI: 10.1016/j.jagp.2024.10.010
Michelle L. Conroy M.D. , Erica C. Garcia-Pittman M.D. , Laura I. van Dyck M.D. , Susan W. Lehmann M.D. , Brandon C. Yarns M.D., M.S.
Objectives
The COVID-19 pandemic caused substantial disruptions in geriatric psychiatry education. In response, the AAGP created the “AAGP COVID-19 Online Trainee Curriculum” (Curriculum) a free online resource consisting of 33 recorded lectures. This study examined the uptake and impact of the Curriculum.
Methods
Administrative data established the number of unique users. Surveys assessed demographics, prior AAGP engagement, prior experiences working with older adults, and each lecture's impact on participant knowledge, enthusiasm and confidence related to the module's topic area.
Results
From May 2020 through April 2023, 860 individuals utilized the Curriculum. Of 251 survey respondents, 54% were general psychiatry residents (37%, n = 91) or medical students (16%, n = 41). Surveys from the two most-accessed lectures showed an increase in knowledge and confidence in clinical skills.
Conclusions
The Curriculum reached medical students and general psychiatry residents. Postpandemic, the Curriculum may serve as a valuable resource to enhance geriatric psychiatry education and knowledge.
{"title":"The COVID-19 American Association for Geriatric Psychiatry (AAGP) Online Trainee Curriculum: Program Evaluation and Future Directions","authors":"Michelle L. Conroy M.D. , Erica C. Garcia-Pittman M.D. , Laura I. van Dyck M.D. , Susan W. Lehmann M.D. , Brandon C. Yarns M.D., M.S.","doi":"10.1016/j.jagp.2024.10.010","DOIUrl":"10.1016/j.jagp.2024.10.010","url":null,"abstract":"<div><h3>Objectives</h3><div>The COVID-19 pandemic caused substantial disruptions in geriatric psychiatry education. In response, the AAGP created the “AAGP COVID-19 Online Trainee Curriculum” (Curriculum) a free online resource consisting of 33 recorded lectures. This study examined the uptake and impact of the Curriculum.</div></div><div><h3>Methods</h3><div>Administrative data established the number of unique users. Surveys assessed demographics, prior AAGP engagement, prior experiences working with older adults, and each lecture's impact on participant knowledge, enthusiasm and confidence related to the module's topic area.</div></div><div><h3>Results</h3><div>From May 2020 through April 2023, 860 individuals utilized the Curriculum. Of 251 survey respondents, 54% were general psychiatry residents (37%, n = 91) or medical students (16%, n = 41). Surveys from the two most-accessed lectures showed an increase in knowledge and confidence in clinical skills.</div></div><div><h3>Conclusions</h3><div>The Curriculum reached medical students and general psychiatry residents. Postpandemic, the Curriculum may serve as a valuable resource to enhance geriatric psychiatry education and knowledge.</div></div>","PeriodicalId":55534,"journal":{"name":"American Journal of Geriatric Psychiatry","volume":"33 3","pages":"Pages 308-314"},"PeriodicalIF":4.4,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}